AI X TECH (01490) announced its interim results, with a net profit attributable to shareholders of 15.808 million yuan, turning a profit compared to the same period last year.
AI X TECH (01490) released its interim results for the six months ended June 30, 2026, reporting revenue of RMB 68.674 million, an increase of 3.5% year-on-year; profit attributable to equity holders of the parent company was RMB 15.808 million, turning a profit from a loss in the same period last year; earnings per share were RMB 0.014.
AI X TECH (01490) announced its interim results for the six months ended June 30, 2026, revealing revenue of RMB 68.674 million, a 3.5% increase year-on-year; profit attributable to equity holders of the parent company was RMB 15.808 million, marking a return to profitability compared to the previous year; earnings per share stood at RMB 0.014.
The announcement stated that the return to profitability was primarily due to the Group's ongoing efforts to promote cost reduction and efficiency improvements, resulting in a significant decrease in operating expenses, coupled with increased income from capital management.
Related Articles

US Stock Market Move | Kanzhun Ltd. Sponsored ADR (BZ.US) surged over 18% with Q2 revenue increasing by 14.1% year-on-year.

US Stock Market Move | The MSCI index exclusion risk strikes again, and Strategy (MSTR.US) has dropped over 4%.

MP CARDIOFLOW-B(02160) has appointed Zhang Ruinian as the company's president.
US Stock Market Move | Kanzhun Ltd. Sponsored ADR (BZ.US) surged over 18% with Q2 revenue increasing by 14.1% year-on-year.

US Stock Market Move | The MSCI index exclusion risk strikes again, and Strategy (MSTR.US) has dropped over 4%.

MP CARDIOFLOW-B(02160) has appointed Zhang Ruinian as the company's president.

RECOMMEND





